Tesamorelin + Ipamorelin Certificate of Analysis (COA) — Canada
This page hosts the current batch Certificate of Analysis (COA) for Tesamorelin + Ipamorelin supplied by Quantum Peptides. Every batch is tested by Peptide Test Canada, an independent Canadian laboratory, by LC-MS/MS (liquid chromatography–tandem mass spectrometry). The full signed report is embedded below and archived at a permanent URL. All material is supplied for laboratory research use only.
Current batch — test summary
| Compound | Tesamorelin + Ipamorelin |
| Report / lot number | COA-2026-SC-00103 |
| Net peptide purity | 98.69% |
| Analytical method | LC-MS/MS (ESI+) |
| Result | PASS |
| Date tested | 06/28/2026 |
| Laboratory | Peptide Test Canada (independent) |
| Appearance | Lyophilized powder |
Download the full Tesamorelin + Ipamorelin Certificate of Analysis (PDF)
About this Certificate of Analysis
A Certificate of Analysis records the analytical identity and net peptide purity of a specific batch. For Tesamorelin + Ipamorelin, quantity and purity are confirmed by LC-MS/MS against the labelled specification. Because each batch is tested and archived separately, this record remains available for reference after a batch has sold through. Quantum Peptides publishes a batch-coded COA for every compound as part of its transparency standard for research buyers in Canada.
Related
- TESA + IPA 40mg — product page
- All Quantum Peptides lab results & batch COAs
- Certificate of Analysis hub — search by peptide
Research use only (RUO). Not for human or veterinary use. This document reports third-party analytical results and is not a drug-release or quality certification.